Amplification of the BP1 homeobox gene in breast cancer

Cancer Genetics and Cytogenetics

Volumn 187, Issue 1, 2008, Pages 19-24

  Cavalli, Luciane R ^a   Man, Yan Gao ^b   Schwartz, Arnold M ^c   Rone, Janice D ^a   Zhang, Ying ^a   Urban, Cicero A ^d   Lima, Rubens S ^e   Haddad, Bassem R ^a   Berg, Patricia E ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

^e FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; HOMEODOMAIN PROTEIN; PROTEIN BP1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CHROMOSOME 17Q; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; RECEPTOR, ERBB-2; SENTINEL LYMPH NODE BIOPSY; TRANSCRIPTION FACTORS;

EID: 55049095635     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.07.004     Document Type: Article

References (24)

1. Chase M.B., Fu S., Haga S.B., Davenport G., Stevenson H., Do K., Morgan D., Mah A.L., and Berg P. BP1, a homeodomain-containing isoform of DLX4, represses the -globin gene. Mol Cell Biol 22 (2002) 2505-2514
2. Fu S.W., Schwartz A., Stevenson H., Pinzone J.J., Davenport G.J., Orenstein J.M., Gutierrez P., Simmens S.J., Abraham J., Poola I., Stephan D.A., and Berg P.E. Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res 5 (2003) 82-87
3. Man Y.-G., Fu S.W., Schwartz A., Pinzone J.J., Simmens S.J., and Berg P.E. Expression of BP1, a novel homeobox gene, correlates with breast cancer progression and invasion. Breast Cancer Res Treat 90 (2005) 241-247
4. Fu S., Stevenson H., Strovel J.W., Haga S.B., Stamberg J., Do K., and Berg P.E. Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 278 (2001) 131-139
5. Mano M.S., Rosa D.D., De Azambuja E., Ismael G.F., and Durbecq V. The 17q12-q21 amplicon: Her2 and topoisomerase-II alpha and their importance to the biology of solid tumours. Cancer Treat Rev 33 (2007) 64-77
6. Dalifard I., Daver A., Goussard J., Lorimier G., Gosse-Brun S., Lorthlary A., and Larra F. p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification. Int J Mol Med 1 (1998) 855-861
7. Mitchell M.S., and Press M.F. The role of immunohistochemistry and fluorescence in situ hybridization for HER2/NEU in assessing the prognosis of breast cancer. Semin Oncol 26 (1999) 108-111
8. Henke R.T., Haddad B.R., Kim S.E., Rone J.D., Mani A., Jessup J.M., Wellstein A., Anirban Maitra A., and Riegel A.T. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clinical Cancer Res 10 (2004) 6134-6142
9. Cullen K.J., Newkirk K.A., Schumaker L.M., Aldosari N., Rone J.D., and Haddad B.R. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cancer Res 63 (2003) 8097-8102
10. Haddad B., Pabon-Pena C., Young H., and Sun W.H. Fine mapping of STAT1 gene by FISH and radiation hybrids. Cytogenet Cell Genet 83 (1998) 58-59
11. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., Dowsett M., Fitzgibbons P.L., Hanna W.M., Langer A., McShane L.M., Paik S., Pegram M.D., Perez E.A., Press M.F., Rhodes A., Sturgeon C., Taube S.E., Tubbs R., Vance G.H., van de Vijver M., Wheeler T.M., and Hayes D.F. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25 (2007) 118-145
12. Monni O., Bärlund M., Mousses S., Kononen J., Sauter G., Heiskanen M., Paavola P., Avela K., Chen Y., Bittner M.L., and Kallioniemi A. Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. Proc Natl Acad Sci USA 98 (2001) 5711-5716
13. Kauraniemi P., Barlund M., Monni O., and Kallioniemi A. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61 (2001) 8235-8240
14. Chen H., and Sukumar S. Role of homeobox genes in normal mammary gland development and breast tumorigenesis. J Mammary Gland Biol Neoplasia 8 (2003) 159-175
15. Makiyama K., Hamada J., Takada M., Murakawa K., Takahashi Y., Tada M., Tamoto E., Shindo G., Matsunaga A., Teramoto K., Komuro K., Kondo S., Katoh H., Koike T., and Moriuchi T. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep 13 (2005) 673-679
16. Wu X., Chen H., Parker B., Rubin E., Zhu T., Lee J.S., Argani P., and Sukumar S. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 66 (2006) 9527-9534
17. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., Kallioniemi O.P., and Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62 (2002) 6240-6245
18. Lewis M.T. Homeobox genes in mammary gland development and neoplasia. Breast Cancer Res 2 (2000) 158-169
19. Clark J., Edwards S., John M., Flohr P., Gordon T., Maillard K., Giddings I., Brown C., Bagherzadeh A., Campbell C., Shipley J., Wooster R., and Cooper C.S. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes Cancer 34 (2002) 104-114
20. Mueller R.E., Parkes R.K., Andrulis I., and O'Malley F.P. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples. Genes Chromosomes Cancer 39 (2004) 288-297
21. Ememura S., Takekoshi S., Suzuki Y., Saitoh Y., Tokuda Y., and Osamura R.Y. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression. Oncol Rep 14 (2005) 337-343
22. Bouchalova K., Trojanec R., Kolar Z., Cwiertka K., Cernakova I., Mihal V., and Hajduch M. Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer. Neoplasma 53 (2006) 393-401
23. Arriola E., Rodriguez-Pinilla S.M., Lambros M.B., Jones R.L., James M., Savage K., Smith I.E., Dowsett M., and Reis-Filho J.S. Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer. Breast Cancer Res Treat 106 (2007) 181-189
24. Nathanson S.D., Slater R., Debruyn D., Kapke A., and Linden M. Her-2/neu expression in primary breast cancer with sentinel lymph node metastasis. Ann Surg Oncol 13 (2006) 205-213